PETS PetMed Express, Inc.
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.…
Industry Peers
Pharmaceutical RetailersKey Statistics
About PetMed Express (NASDAQ: PETS)
›
PetMed Express (NASDAQ: PETS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector, and reports about 189 employees.
The shares were at 0.9244 USD on 19 November 2026, down 63.2% over 52 weeks. Its 52-week range is 0.8500 USD to 4.100 USD: the price is 77.5% below the high and 8.8% above the low.
Its market capitalisation is 20.55M USD.
PetMed Express reports return on equity of -197.9%, an operating margin of -16.9% and revenue down 19.4% year over year.
It holds more cash than debt, a net cash position of 11.13M USD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.